ArticleJournal of the National Cancer Institute2024

Probing the relevance of BRCA1 and BRCA2 germline pathogenic variants beyond breast and ovarian cancer.

William D Foulkes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.